Atai Life Sciences announces common shares offering, no amount given

atai Life Sciences (ATAI) announced the commencement of a proposed registered underwritten offering of its common shares. All common shares to be sold in the offering will be sold by atai. atai intends to use the net proceeds of this offering, together with existing cash, cash equivalents and short-term investments, to advance the clinical development of its product candidates and programs, as well as for working capital and general corporate purposes. Jefferies is the lead bookrunner for the offering. Berenberg Capital Markets is also acting as passive bookrunner for the offering. Canaccord Genuity and Oppenheimer & Co. are acting as co-managers for the offering.